Serum Heparanase: A New Clinical Biomarker Involved in Senile Metabolic Inflammatory Syndrome

References

• Hu RM . Concept and clinical significance of metabolic inflammatory syndrome. Clinical Focus . 2016;31(09):960–963.
   Google Scholar
• Wang F , Wan A , Rodrigues B . The function of heparanase in diabetes and its complications. Can J Diabetes . 2013;37(5):332–338. doi:10.1016/j.jcjd.2013.05.008 24500561
   PubMed Web of Science ®Google Scholar
• Irving-Rodgers HF , Ziolkowski AF , Parish CR , et al. Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia . 2008;51(9):1680–1688. doi:10.1007/s00125-008-1085-x 18633594
   PubMed Web of Science ®Google Scholar
• Shafat I , Ilan N , Zoabi S , Vlodavsky I , Nakhoul F . Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels. PLoS One . 2011;6(2):e17312. doi:10.1371/journal.pone.0017312 21364956
   PubMed Web of Science ®Google Scholar
• Baker AB , Chatzizisis YS , Beigel R , et al. Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine. Atherosclerosis . 2010;213(2):436–442. doi:10.1016/j.atherosclerosis.2010.09.003 20950809
   PubMed Web of Science ®Google Scholar
• Muhammad RS , Abu-Saleh N , Kinaneh S , et al. Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E0 mice. Atherosclerosis . 2018;276:155–162. doi:10.1016/j.atherosclerosis.2018.07.026 30075439
   PubMed Web of Science ®Google Scholar
• Colman PG , Thomas DW , Zimmet PZ , Welborn TA , Garcia-Webb P , Moore MP . New classification and criteria for diagnosis of diabetes mellitus. The Australasian Working Party on Diagnostic Criteria for Diabetes Mellitus. N Z Med J . 1999;112(1086):139–141.10340693
   PubMed Web of Science ®Google Scholar
• Review T , LaBrecque DR , Abbas Z , et al. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol . 2014;48(6):467–473. doi:10.1097/MCG.0000000000000116 24921212
   PubMed Web of Science ®Google Scholar
• Kinoshita M , Yokote K , Arai H , et al. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb . 2018;25(9):846–984. doi:10.5551/jat.GL2017 30135334
   PubMed Web of Science ®Google Scholar
• Li Y , Teng D , Shi X , et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ . 2020;369:m997. doi:10.1136/bmj.m997 32345662
   PubMed Web of Science ®Google Scholar
• Aamir K , Khan HU , Sethi G , Hossain MA , Arya A . Wnt signaling mediates TLR pathway and promote unrestrained adipogenesis and metaflammation: therapeutic targets for obesity and type 2 diabetes. Pharmacol Res . 2020;152:104602. doi:10.1016/j.phrs.2019.104602 31846761
   PubMed Web of Science ®Google Scholar
• Nasonov EL , Popkova TV . Atherosclerosis: perspectives of anti-inflammatory therapy. Terapevt Arkh . 2018;90(5):4–12.
   PubMed Web of Science ®Google Scholar
• Lefere S , Tacke F . Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism. JHEP Rep . 2019;1(1):30–43. doi:10.1016/j.jhepr.2019.02.004 32149275
   PubMedGoogle Scholar
• Ma L , Xu Y , Zhang Y , Ji T , Li Y . Lower Levels of Circulating Adiponectin in Elderly Patients with Metabolic Inflammatory Syndrome: a Cross-Sectional Study. Diabetes Metab Syndr Obes . 2020;13:591–596. doi:10.2147/DMSO.S242397 32184638
   PubMed Web of Science ®Google Scholar
• Liu LP , Sheng XP , Shuai TK , Zhao YX , Li B , Li YM . Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression. World J Gastroenterol . 2018;24(40):4565–4577. doi:10.3748/wjg.v24.i40.4565 30386106
   PubMed Web of Science ®Google Scholar
• Sun X , Zhang GL , Nian JY , et al. Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data. Oncotarget . 2017;8(26):43521–43535. doi:10.18632/oncotarget.16575 28388549
   PubMedGoogle Scholar
• Khasraw M , Pavlakis N , McCowatt S , et al. Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer. Ann Oncol . 2010;21(6):1302–1307. doi:10.1093/annonc/mdp524 19917571
   PubMed Web of Science ®Google Scholar
• Meirovitz A , Goldberg R , Binder A , Rubinstein AM , Hermano E , Elkin M . Heparanase in inflammation and inflammation-associated cancer. FEBS J . 2013;280(10):2307–2319. doi:10.1111/febs.12184 23398975
   PubMed Web of Science ®Google Scholar
• Digre A , Singh K , Abrink M , et al. Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis. Sci Rep . 2017;7:46229. doi:10.1038/srep46229 28401953
   PubMed Web of Science ®Google Scholar
• Quaglio AE , Castilho AC , Di Stasi LC . Experimental evidence of heparanase, Hsp70 and NF-kappaB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation. Life Sci . 2015;141:179–187. doi:10.1016/j.lfs.2015.09.023 26434698
   PubMed Web of Science ®Google Scholar
• Li RM , Hu RM . Progress in the pathogenesis of metabolic inflammatory syndrome. Fudan Univ J Med Sci . 2017;44(03):380–384.
   Google Scholar
• van Woudenbergh GJ , Theofylaktopoulou D , Kuijsten A , et al. Adapted dietary inflammatory index and its association with a summary score for low-grade inflammation and markers of glucose metabolism: the Cohort study on Diabetes and Atherosclerosis Maastricht (CODAM) and the Hoorn study. Am J Clin Nutr . 2013;98(6):1533–1542. doi:10.3945/ajcn.112.056333 24153342
   PubMed Web of Science ®Google Scholar
• Zheng S , Liu E , Zhang Y , et al. Circulating zinc-alpha2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment. Endocr J . 2019;66(6):555–562. doi:10.1507/endocrj.EJ18-0153 30918134
   PubMed Web of Science ®Google Scholar
• Schutt KA . [Evidence-based reduction of cardiovascular risk in patients with diabetes]. Herz . 2020;45(2):118–121. doi:10.1007/s00059-019-04876-0 31820029
   PubMed Web of Science ®Google Scholar
• Abdin AA , Baalash AA , Hamooda HE . Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers. J Diabetes Complicat . 2010;24(3):168–178. doi:10.1016/j.jdiacomp.2009.01.005
   PubMed Web of Science ®Google Scholar
• Hundal RS , Petersen KF , Mayerson AB , et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest . 2002;109(10):1321–1326. doi:10.1172/JCI0214955 12021247
   PubMed Web of Science ®Google Scholar
• Dai XY , Yan J , Fu XH , et al. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase. Clin Cancer Res . 2017;23(20):6267–6278. doi:10.1158/1078-0432.CCR-17-0242 28710312
   PubMed Web of Science ®Google Scholar